Oyster Point Pharma, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD from Q4 2018 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Oyster Point Pharma, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and growth rate from Q4 2018 to Q3 2022.
  • Oyster Point Pharma, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending September 30, 2022 was $646K, a 413% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $646K +$520K +413% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $646K +$520K +413% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $572K +$446K +354% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $666K +$411K +161% Dec 31, 2021 10-K 2022-02-24
Q3 2021 $126K -$128K -50.4% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $126K -$306K -70.8% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $126K -$306K -70.8% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $255K Dec 31, 2020 10-K 2021-02-18
Q3 2020 $254K -$65K -20.4% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $432K Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $432K Mar 31, 2020 10-Q 2020-05-11
Q3 2019 $319K Sep 30, 2019 10-Q 2019-12-03
Q4 2018 $7K Dec 31, 2018 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.